Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gepotidacin versus nitrofurantoin for uncomplicated urinary tract infection (acute cystitis)
2018-001801-98Phase 3Unknown
- Sponsor
- GSK
- Start
- Sep 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in urinary tract infection (UTI) and acute cystitis comparing Gepotidacin arm with Nitrofurantoin arm (2 arms). Primary endpoint: Therapeutic response at the Test-of-Cure visit. Status: unknown.
02
Drugs
gepotidacinnitrofurantoin
03
Conditions
urinary tract infection (UTI)acute cystitis
Beyond the preview
Go deeper on 2018-001801-98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001801-98.